Thrivent Financial for Lutherans Sells 9,989 Shares of Mettler-Toledo International, Inc. $MTD

Thrivent Financial for Lutherans lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 53.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,635 shares of the medical instruments supplier’s stock after selling 9,989 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Mettler-Toledo International were worth $10,144,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Sound Income Strategies LLC boosted its stake in Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 43 shares in the last quarter. Acadian Asset Management LLC increased its position in shares of Mettler-Toledo International by 84.9% during the first quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock worth $2,965,000 after purchasing an additional 1,154 shares in the last quarter. Stance Capital LLC purchased a new stake in shares of Mettler-Toledo International during the 2nd quarter valued at $2,012,000. Focus Partners Wealth boosted its position in shares of Mettler-Toledo International by 85.6% in the 1st quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier’s stock worth $3,774,000 after purchasing an additional 1,474 shares in the last quarter. Finally, CW Advisors LLC grew its stake in Mettler-Toledo International by 250.3% during the 1st quarter. CW Advisors LLC now owns 620 shares of the medical instruments supplier’s stock worth $737,000 after buying an additional 443 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Barclays lowered their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a report on Monday. JPMorgan Chase & Co. lifted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Citigroup raised their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Finally, The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective on the stock. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,441.67.

Insider Buying and Selling at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 1,895 shares of the business’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the completion of the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,696,789.76. The trade was a 26.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider La Guerroniere Marc De sold 6,880 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the sale, the insider owned 187 shares in the company, valued at $271,150. The trade was a 97.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 19,565 shares of company stock worth $28,683,737. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Down 0.1%

MTD opened at $1,384.84 on Thursday. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,525.17. The firm has a 50 day moving average of $1,406.27 and a two-hundred day moving average of $1,297.87. The firm has a market capitalization of $28.29 billion, a PE ratio of 34.53, a P/E/G ratio of 4.48 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.